PRESS RELEASEFollowing Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

The U.S. FDA recently cleared Medtronic plc’s Hugo robotic-assisted surgery system and CMR Surgical Ltd.’s Versius Plus system, adding new options to the U.S. market to meet rising demand for robotic ...

CMR Surgical announced today that it submitted a 510(k) premarket notification to the FDA for its Versius Plus surgical robot ...

The MarketWatch News Department was not involved in the creation of this content. Cambridge-based surgical robotics company contributes majority of surgical data to world's largest open healthcare ...

Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...

Milestone announcement at SAGES 2026 underscores accelerating adoption of Versius as CMR prepares for U.S. expansion following recent FDA clearance CAMBRIDGE, UK and TAMPA, FL – March 26, 2026 — CMR ...

Cambridge-based surgical robotics company contributes majority of surgical data to world’s largest open healthcare robotics dataset Cambridge, UK and San Jose, California – 16 March 2026, CMR Surgical ...